AboyansVRiccoJ-BBartelinkM-LEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO); The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39:763–816.
2.
Gerhard-HermanMDGornikHLBarrettC, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:e71–e126.
3.
SogaYIidaOTakaharaM, et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv. 2014;7:1444–1449.
4.
KristensenMTHolmGKirketerp-MøllerK, et al. Very low survival rates after non-traumatic lower limb amputation in a consecutive series: what to do?Interact Cardiovasc Thorac Surg. 2012;14:543–547.
5.
GiannopoulosSVarcoeRLLichtenbergM, et al. Balloon angioplasty of infrapopliteal arteries: a systematic review and proposed algorithm for optimal endovascular therapy. J Endovasc Ther. 2020;27(4):547–564.
6.
ZellerTBeschornerUPilgerE, et al. Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK’S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). JACC Cardiovasc Interv. 2015;8:1614–1622.
7.
LiistroFPortoIAngioliP, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013;128:615–621.
8.
KatsanosKSpiliopoulosSKitrouP, et al. Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2018;7:e011245.
9.
KatsanosKSpiliopoulosSKitrouP, et al. Risk of death and amputation with use of paclitaxel-coated balloons in the infrapopliteal arteries for treatment of critical limb ischemia: a systematic review and meta-analysis of randomized controlled trials. J Vasc Interv Radiol. 2020;31:202–212.
10.
ZellerTBaumgartnerIScheinertD, et al. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. J Am Coll Cardiol. 2014;64:1568–1576.
11.
SiablisDKitrouPMSpiliopoulosS, et al. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. JACC Cardiovasc Interv. 2014;7:1048–1056.
12.
KarnabatidisDSpiliopoulosSDiamantopoulosA, et al. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther. 2011;18:1–12.
13.
SpreenMIMartensJMKnippenbergB, et al. Long-term follow-up of the PADI trial: percutaneous transluminal angioplasty versus drug-eluting stents for infrapopliteal lesions in critical limb ischemia. J Am Heart Assoc. 2017;6:e004877.
14.
ScheinertDKatsanosKZellerT, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol. 2012;60:2290–2295.
15.
GeraghtyPJAdamsGLSchmidtA, et al. Twelve-month results of Tack-optimized balloon angioplasty using the Tack Endovascular System in below-the-knee arteries (TOBA II BTK). J Endovasc Ther. 2020;27(4:626–636.
16.
GeraghtyPJAdamsGL.How well does the Tack Endovascular System work with BTK balloon angioplasty: TOBA II BTK pivotal trial results for a BTK Tack implant. Abstract presented at: The Veith Symposium; November 21, 2019; New York, NY, USA.
TepeGZellerTSchnorrB, et al. High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study. J Endovasc Ther. 2013;20:792–800.
19.
ShammasNWShammasWJJones-MillerS, et al. Optimal vessel sizing and understanding dissections in infrapopliteal interventions: data from the iDissection Below the Knee Study. J Endovasc Ther. 2020;27(4:575–580.
20.
ShammasNWToreyJTShammasWJ, et al. Intravascular ultrasound assessment and correlation with angiographic findings demonstrating femoropopliteal arterial dissections post atherectomy: results from the iDissection study. J Invasive Cardiol. 2018;30:240–244.
21.
ShammasNWToreyJTShammasWJ.Dissections in peripheral vascular interventions: a proposed classification using intravascular ultrasound. J Invasive Cardiol. 2018;30:145–146.
22.
PliagasGSaabFStavroulakisK, et al. Intravascular ultrasound imaging versus digital subtraction angiography in patients with peripheral vascular disease. J Invasive Cardiol. 2020;32:99–103.
23.
IidaOTakaharaMSogaY, et al. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther. 2014;21:485–492.
24.
ZhangJGaoXKanJ, et al. Intravascular ultrasound versus angiography-guided drug-eluting stent implantation: the ULTIMATE trial. J Am Coll Cardiol. 2018;72:3126–3137.
25.
HongSJKimBKShinDH, et al. Effect of intravascular ultrasound-guided vs angiography-guided everolimus-eluting stent implantation: the IVUS-XPL randomized clinical trial. JAMA. 2015;314:2155–2163.
26.
ToninoPADe BruyneBPijlsNH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360:213–224.
27.
SmitsPCAbdel-WahabMNeumannFJ, et al. Fractional flow reserve-guided multivessel angioplasty in myocardial infarction. N Engl J Med. 2017;376:1234–1244.
28.
VarcoeRLThomasSDLennoxAF.Three-year results of the Absorb everolimus-eluting bioresorbable vascular scaffold in infrapopliteal arteries. J Endovasc Ther. 2018;25:694–701.
29.
VarcoeRL.Five-year results from ABSORB BTK trial. Abstract presented at: VIVA 2019; November 4–7, 2019; Las Vegas, NV, USA.
